Cite
Benhaim L, Bouché O, Normand C, et al. Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS). Eur J Cancer. 2021;159:24-33doi: 10.1016/j.ejca.2021.09.004.
Benhaim, L., Bouché, O., Normand, C., Didelot, A., Mulot, C., Le Corre, D., Garrigou, S., Djadi-Prat, J., Wang-Renault, S. F., Perez-Toralla, K., Pekin, D., Poulet, G., Landi, B., Taieb, J., Selvy, M., Emile, J. F., Lecomte, T., Blons, H., Chatellier, G., Link, D. R., Taly, V., & Laurent-Puig, P. (2021). Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS). European journal of cancer (Oxford, England : 1990), 15924-33. https://doi.org/10.1016/j.ejca.2021.09.004
Benhaim, Leonor, et al. "Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS)." European journal of cancer (Oxford, England : 1990) vol. 159 (2021): 24-33. doi: https://doi.org/10.1016/j.ejca.2021.09.004
Benhaim L, Bouché O, Normand C, Didelot A, Mulot C, Le Corre D, Garrigou S, Djadi-Prat J, Wang-Renault SF, Perez-Toralla K, Pekin D, Poulet G, Landi B, Taieb J, Selvy M, Emile JF, Lecomte T, Blons H, Chatellier G, Link DR, Taly V, Laurent-Puig P. Circulating tumor DNA is a prognostic marker of tumor recurrence in stage II and III colorectal cancer: multicentric, prospective cohort study (ALGECOLS). Eur J Cancer. 2021 Dec;159:24-33. doi: 10.1016/j.ejca.2021.09.004. Epub 2021 Oct 30. PMID: 34731746.
Copy
Download .nbib